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Obstetrics and GynecologyIn this issue of the Journal, we are pleased to introduce the win-
ners of the 2015 Taiwanese Journal of Obstetrics and Gynecology
(TJOG) Outstanding Research Paper Award. The awards were selected
from among research papers published in the 2015 print issues of
the TJOG. The 2015 TJOG Outstanding Research Paper Golden
Award winner was Dr. Wang, for his research paper entitled “The
role of nitric oxide in the outgrowth of trophoblast cells on human
umbilical vein endothelial cells” [1]. The 2015 TJOG Outstanding
Research Paper Silver Award winner was Dr. Chen, for her research
paper entitled “Iron stores and obesity are negatively associated
with ovarian volume and anti-Müllerian hormone levels in women
with polycystic ovary syndrome” [2]. Both winners received their
honors at the Annual Meeting of the Taiwan Association of Obstet-
rics and Gynecology on March 5, 2016 and March 6, 2016, held in
Taipei, Taiwan.
The golden award-winning research article was published in the
June 2015 issue. This article was cooperated by two institutes to ﬁn-
ish this work, including two directors of the reproductive medicine
in both institutes (Dr. Kuan Hao Tsui and Dr. Hsin-Yang Li). The re-
sults showed that N(G)-nitro-L-arginine methyl ester hydrochlo-
ride (L-NAME), a competitive inhibitor of nitric oxide synthase
(NOS), could diminish spheroid expansion on human umbilical
vein endothelial cell (HUVEC) monolayers in a concentration-
dependent manner (p< 0.05), suggesting the importance of
nitric oxide (NO) availability. However, a higher dose (1mM) of
sodium nitroprusside (SNP), an NO donor, signiﬁcantly suppressed
spheroid expansion, suggesting that the overproduction of NO
might impede the normal interaction between trophoblast and
HUVEC [1]. The study further showed that trophoblast spreading
on HUVEC-free culture surface was not affected by NOS inhibitor
or NO, conﬁrming that NO is needed on the interaction between
trophoblast and HUVEC. Taken together, the authors concluded
that the interaction of trophoblasts and HUVEC is dependent on
an adequate and approximate NO-containing environment, and
either over or under NO environment will deteriorate the interac-
tion between trophoblast and HUVEC [1].
The silver award-winning research article by Dr. Mei-Jou Chen
was published in the December 2015 issue [2]. The authors found
that polycystic ovary syndrome (PCOS) women with obesity had
signiﬁcantly higher ferritin, and lower anti-Müllerian hormone
(AMH) levels than PCOS women without obesity. In the earlier
August 2015 issue, Drs. Ming-I Hsu and Chun-Sen Hsu published
a similar paper, but this article focused on the relationship be-
tween serum ferritin levels and PCO-related complication [3].http://dx.doi.org/10.1016/j.tjog.2016.05.006
1028-4559/Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published b
(http://creativecommons.org/licenses/by-nc-nd/4.0/).The results showed that the correlation of serum ferritin levels
and PCO-related complication is strong and positive in PCO
women with obesity, but not in PCO women with a normal body
weight, because elevated serum ferritin levels were associated
with an increased insulin resistance and an increased risk of dia-
betes mellitus (DM), but this association is only apparent in the
obesity group [3]. In fact, both Drs. Chen and Hsu's studies pro-
posed that “iron overload” (elevated serum ferritin levels) might
be common in PCO patients; however, it is often neglected in clin-
ical practice. Based on the ﬁndings of both studies, evaluation of
patients with PCO for anemia and/or iron metabolism might be
important. It is well known that uncontrolled iron overload is
associated with serous clinical consequences and further results
in considerable morbidity and mortality, regardless of gender
[4]. This deteriorated health effect of “iron overload” is also
apparent in children [4]. The iron overload-related complications
included liver damage, cardiac disease, and endocrine dysfunction.
Among the category of endocrine dysfunctions, DM might be one
of the most common and important “iron-overload”-related com-
plications. Both articles in the 2015 print issues of the TJOG
conﬁrmed the positive correlation between “iron-overload” and
insulin resistance or DM [2,3], suggesting that the management
of PCO women is complicated and needs more attention [5].
In general, subfertility is commonly reported in PCOwomen, ac-
cording to long-term anovulation [6]. However, neither impaired
ovarian function nor decreased ovarian reserve has been recog-
nized in PCO women. By contrast, PCO women often had a higher
level of AMH compared with healthy controls did [7], suggesting
the ovarian reserve might be better in PCO women. AMH is a
good indicator to predict the ovarian function and ovarian reserve,
with higher levels of AMH for better ovarian reserve and function
[7]. Dr. Chen found that “iron-overload” might be associated with
lower serum levels of AMH in these PCOwomenwith obesity, hint-
ing to us the possibility these PCO women might have a potential
risk of declining ovarian reserve and function, especially for those
PCO women with obesity. Based on the fact that overstimulation
of the ovary is much more frequent in PCO women than in normal
controls when ovulation induction is applied and the observation of
low levels of AMH in PCOwomenwith obesity, it suggested that we
should pay close attention to the use of assisted reproductive tech-
niques for those PCO women who need ovulation-induction
protocols.
We are also happy to introduce the winner of the best paper
award of Professor Lee Tzu-Yao's Foundation for Reproductivey Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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Dr. Mei-Jou Chen is the biggest winner at the Annual Meeting of the
Taiwan Association of Obstetrics and Gynecology because she ob-
tained two awards this year. In this excellent award, the title of
this article is “The effect of androgens on ovarian follicle matura-
tion: dihydrotestosterone suppress FSH-stimulated granulosa cell
proliferation by upregulating PPARg-dependent PTEN expression”,
which evaluated the effect of androgens on ovarian follicle matura-
tion [8]. The authors found that the dihydrotestosterone (DHT)-
treated rats had fewer estrus cycles, higher numbers of large
arrested follicles, and an increase in body weight gain compared
with dehydroepiandrostenedione (DHEA)- and placebo-treated
rats. Further dissecting the mechanism, the authors found that
alternation of granulosa cell proliferation might be a key compo-
nent, and this was mediated through the regulation of enhancing
peroxisome proliferator-activated receptor gamma-dependent
phosphatase and tensin homolog deleted on chromosome 10/phos-
phorylated protein kinase B (PPARg dependent PTEN/p-Akt)
expression in the granulosa cells. Dr. Chen's study demonstrated
that chronic exposure of DHT or DHEA induces differential effects
on body weight change, visceral and subcutaneous fat, and meta-
bolic abnormalities in prepubertal female rats, and showed that
only DHT treatment deteriorated the ovarian function [8]. Although
their study did not directly support the theory that DHEA might be
beneﬁcial for women with poor responders, however, at least, the
authors indirectly supported the view that the effect of DHEA on
ovarian function might not be totally mediated though the classic
way of androgeneandrogen receptor (DHTda most potent ligand
for androgen receptor). Based on our previous studies [9e11],
DHEA could be applied in women with poor responders, because
of its potential beneﬁt in these women with poor responders.
We are pleased to congratulate both of our award-winning doc-
tors on their winning of the TJOG Outstanding Research Article
Award, especially Dr. Chen for her extremely important contribu-
tion to global health problemsdpolycystic ovary syndrome. Finally,
wewelcome the authors' or readers' continuing interest and contri-
bution to the TJOG [12,13].
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